These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 25682238

  • 1. Anti-tumor effect of the mammalian target of rapamycin inhibitor everolimus in oral squamous cell carcinoma.
    Naruse T, Yanamoto S, Yamada S, Rokutanda S, Kawakita A, Kawasaki G, Umeda M.
    Pathol Oncol Res; 2015 Jul; 21(3):765-73. PubMed ID: 25682238
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
    Wang Q, Zhang X, Song X, Zhang L.
    Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
    [Abstract] [Full Text] [Related]

  • 4. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W, Song X, Yang X, Ma L, Zhu J, He M, Wang Z, Wu Y.
    PLoS One; 2014 Dec; 9(7):e101931. PubMed ID: 24999732
    [Abstract] [Full Text] [Related]

  • 5. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
    Zhang H, Zhang J, Nan X, Li X, Qu J, Hong Y, Sun L, Chen Y, Li T.
    Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alterations of hypoxia-induced factor signaling pathway due to mammalian target of rapamycin (mTOR) suppression in ovarian clear cell adenocarcinoma: in vivo and in vitro explorations for clinical trial.
    Hirasawa T, Miyazawa M, Yasuda M, Shida M, Ikeda M, Kajiwara H, Matsui N, Fujita M, Muramatsu T, Mikami M.
    Int J Gynecol Cancer; 2013 Sep; 23(7):1210-8. PubMed ID: 23899586
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo.
    Yasuda A, Kondo S, Nagumo T, Tsukamoto H, Mukudai Y, Umezawa K, Shintani S.
    Oral Oncol; 2011 May; 47(5):334-9. PubMed ID: 21459660
    [Abstract] [Full Text] [Related]

  • 11. NVP-BEZ235 Attenuated Cell Proliferation and Migration in the Squamous Cell Carcinoma of Oral Cavities and p70S6K Inhibition Mimics its Effect.
    Hsu CM, Lin PM, Lin HC, Tsai YT, Tsai MS, Li SH, Wu CY, Yang YH, Lin SF, Yang MY.
    Int J Mol Sci; 2018 Nov 10; 19(11):. PubMed ID: 30423811
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro.
    Gao L, Dong J, Zhang N, Le Z, Ren W, Li S, Li F, Song J, Wang Q, Dou Z, Park SY, Zhi K.
    Anticancer Agents Med Chem; 2019 Nov 10; 19(2):248-255. PubMed ID: 30378503
    [Abstract] [Full Text] [Related]

  • 13. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
    Harada K, Ferdous T, Harada T, Ueyama Y.
    Int J Oncol; 2016 Jul 10; 49(1):276-84. PubMed ID: 27210058
    [Abstract] [Full Text] [Related]

  • 14. EPHA2 Promotes the Invasion and Migration of Human Tongue Squamous Cell Carcinoma Cal-27 Cells by Enhancing AKT/mTOR Signaling Pathway.
    Wang F, Zhang H, Cheng Z.
    Biomed Res Int; 2021 Jul 10; 2021():4219690. PubMed ID: 33834064
    [Abstract] [Full Text] [Related]

  • 15. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
    Liu R, Peng J, Wang H, Li L, Wen X, Tan Y, Zhang L, Wan H, Chen F, Nie X.
    Cell Physiol Biochem; 2018 Jul 10; 49(5):1717-1733. PubMed ID: 30231242
    [Abstract] [Full Text] [Related]

  • 16. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
    Pivonello C, Negri M, De Martino MC, Napolitano M, de Angelis C, Provvisiero DP, Cuomo G, Auriemma RS, Simeoli C, Izzo F, Colao A, Hofland LJ, Pivonello R.
    Oncotarget; 2016 Mar 01; 7(9):9718-31. PubMed ID: 26756219
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
    Chiba T, Ishisaki A, Kyakumoto S, Shibata T, Yamada H, Kamo M.
    Oncol Rep; 2017 Feb 01; 37(2):713-720. PubMed ID: 28035402
    [Abstract] [Full Text] [Related]

  • 18. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S, Miyata H, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y.
    Ann Surg Oncol; 2015 Dec 01; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [Abstract] [Full Text] [Related]

  • 19. Loss of keratin 8 phosphorylation leads to increased tumor progression and correlates with clinico-pathological parameters of OSCC patients.
    Alam H, Gangadaran P, Bhate AV, Chaukar DA, Sawant SS, Tiwari R, Bobade J, Kannan S, D'cruz AK, Kane S, Vaidya MM.
    PLoS One; 2011 Dec 01; 6(11):e27767. PubMed ID: 22114688
    [Abstract] [Full Text] [Related]

  • 20. Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells.
    Zhang W, Liu Y, Li YF, Yue Y, Yang X, Peng L.
    Cell Physiol Biochem; 2016 Dec 01; 38(6):2426-37. PubMed ID: 27287458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.